scholarly journals The Effectiveness of Injection of Trigger Points with Platelet Rich Plasma as A Pain Management Method in Chronic Tension Type Headache: فعالية حقن نقاط التوتر بالصفائح الغنية بالبلازما كطريقة لمعالجة الآلام المزمنة في الصداع التوتري المزمن

2019 ◽  
Vol 3 (4) ◽  
Author(s):  
Hayder Ghali Algawwam, Abdullah Ahmed Mohammad
Keyword(s):  
Pain Management ◽  
Platelet Rich Plasma ◽  
Trigger Points ◽  
Tension Type Headache ◽  
Response To Therapy ◽  
Response To Treatment ◽  
Chronic Tension Type Headache ◽  
Significant Difference ◽  
Management Method ◽  
Type Headache

    Objective: This study designed to evaluate the effectiveness of injection of trigger points with platelet rich plasma as a pain management method in chronic tension type headache. Methodology: a retrospective study conducted over 2.5 year period (July 1, 2016- March 31, 2018), 71 patients (57 females and 14 males) in Dr Abdullah Al-Karboli Medical Center For Family Medicine And Pain Management in Kirkuk, Iraq because of CTTH, they received trigger points PRP injections. The PRP was prepared by centrifuging patients’ own blood. The response to therapy was graded as excellent, good, fair and poor. Results: The mean age was 48.1± 1.5 years. Most of patients (n: 52, 73.2%) yielded either good or excellent response to treatment, while (n: 19, 26.8%) from patient had either fair or poor response to treatment, there was statistically significant difference between the 2 groups. Conclusion: Trigger points injection with PRP seems to be an effective, safe and cheap pain management method in CTTH.    

scholarly journals Effectiveness of Injection of Trigger Points with Platelet Rich Plasma as A Pain Management Method in Rotator Cuff Syndrome: إدارة الآلام المزمنة في متلازمة الكفة المدورة بواسطة زرق نقاط التوتر بالبلازما الغنية بالصفائح الدموية

2020 ◽  
Vol 4 (4) ◽  
Author(s):  
Hayder Ghali Algawwam, Abdullah Ahmed Mohammad
Keyword(s):  
Chronic Pain ◽  
Pain Management ◽  
Rotator Cuff ◽  
Platelet Rich Plasma ◽  
Poor Response ◽  
Trigger Points ◽  
Response To Therapy ◽  
Response To Treatment ◽  
Significant Difference ◽  
Management Method

Objective The aim of the current study is to evaluate the effectiveness of the injection of trigger points with platelet-rich plasma as a pain management method in chronic pain resulting from rotator cuff syndrome. Methodology A retrospective study was designed for the period from August 1, 2016, until July 31, 2019, 36 patients (21 females and 15 males) visited our private clinic in Kirkuk, Iraq because of chronic shoulder pain, they received trigger points PRP injections. The PRP was prepared by centrifuging the patient's own blood. The response to therapy was graded: excellent, good, fair and poor. Results The mean age was 52.3± 1.9 years. Most of the patients (n: 33, 92%) had either overweight or obesity and (n: 16, 44.6%) had hypertension either alone or in combination with diabetes mellitus. Most of the patients (n: 30, 83.3%) received three sessions while (n: 6, 16.7%) received one session of PRP injections. Most of the patients (n: 28, 77.8%) yielded either good or excellent response to treatment, while (n: 8, 22.2%) from the patient had an either fair or poor response to treatment, there was a statistically significant difference (p˂0.01) between the 2 groups. Conclusion PRP injections of trigger points in patients complaining from chronic pain as a result of rotator cuff syndrome seem to be an effective, safe and cheap pain management method.

The Local and Referred Pain From Myofascial Trigger Points in the Temporalis Muscle Contributes to Pain Profile in Chronic Tension-type Headache

2007 ◽  
Vol 23 (9) ◽  
pp. 786-792 ◽  
Author(s):  
César Fernández-de-las-Peñas ◽  
Hong-You Ge ◽  
Lars Arendt-Nielsen ◽  
Maria Luz Cuadrado ◽  
Juan A. Pareja
Keyword(s):  
Trigger Points ◽  
Tension Type Headache ◽  
Referred Pain ◽  
Temporalis Muscle ◽  
Myofascial Trigger Points ◽  
Chronic Tension Type Headache ◽  
Type Headache

Myofascial Trigger Points Are Very Prevalent in Patients With Chronic Tension-type Headache

2007 ◽  
Vol 23 (1) ◽  
pp. 23-27 ◽  
Author(s):  
Christian Coupp?? ◽  
Paola Torelli ◽  
Anders Fuglsang-Frederiksen ◽  
Kjeld Visti Andersen ◽  
Rigmor Jensen
Keyword(s):  
Trigger Points ◽  
Tension Type Headache ◽  
Myofascial Trigger Points ◽  
Chronic Tension Type Headache ◽  
Type Headache

Referred pain areas of active myofascial trigger points in head, neck, and shoulder muscles, in chronic tension type headache

2010 ◽  
Vol 14 (4) ◽  
pp. 391-396 ◽  
Author(s):  
César Fernández-de-las-Peñas ◽  
Hong-You Ge ◽  
Cristina Alonso-Blanco ◽  
Javier González-Iglesias ◽  
Lars Arendt-Nielsen
Keyword(s):  
Trigger Points ◽  
Tension Type Headache ◽  
Referred Pain ◽  
Myofascial Trigger Points ◽  
Chronic Tension Type Headache ◽  
Shoulder Muscles ◽  
Type Headache ◽  
Head Neck

scholarly journals Referred pain from myofascial trigger points in head and neck–shoulder muscles reproduces head pain features in children with chronic tension type headache

2011 ◽  
Vol 12 (1) ◽  
pp. 35-43 ◽  
Author(s):  
César Fernández-de-las-Peñas ◽  
Daniel M. Fernández-Mayoralas ◽  
Ricardo Ortega-Santiago ◽  
Silvia Ambite-Quesada ◽  
Domingo Palacios-Ceña ◽  
...  
Keyword(s):  
Head And Neck ◽  
Trigger Points ◽  
Tension Type Headache ◽  
Referred Pain ◽  
Myofascial Trigger Points ◽  
Chronic Tension Type Headache ◽  
Head Pain ◽  
Shoulder Muscles ◽  
Type Headache

scholarly journals Botulinum Toxin Type A in the Prophylactic Treatment of Chronic Tension-Type Headache: A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study

Cephalalgia ◽  
2006 ◽  
Vol 26 (7) ◽  
pp. 790-800 ◽  
Author(s):  
SD Silberstein ◽  
H Göbel ◽  
R Jensen ◽  
AH Elkind ◽  
R DeGryse ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Primary Endpoint ◽  
Botulinum Toxin Type A ◽  
Tension Headache ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Tension Type Headache ◽  
Chronic Tension Type Headache ◽  
Significant Difference ◽  
Type Headache

We studied the safety and efficacy of 0 U, 50 U, 100 U, 150 U (five sites), 86 Usub and 100 Usub (three sites) botulinum toxin type A (BoNTA; BOTOX®; Allergan, Inc., Irvine, CA, USA) for the prophylaxis of chronic tension-type headache (CTTH). Three hundred patients (62.3± female; mean age 42.6 years) enrolled. For the primary endpoint, the mean change from baseline in the number of TTH-free days per month, there was no statistically significant difference between placebo and four BoNTA groups, but a significant difference favouring placebo vs. BoNTA 150 was observed (4.5 vs. 2.8 tension headache-free days/month; P = 0.007). All treatment groups improved at day 60. Although efficacy was not demonstrated for the primary endpoint, at day 90, more patients in three BoNTA groups had ≥50± decrease in tension headache days than did placebo ( P ≤ 0.024). Most treatment-related adverse events were mild or moderate, and transient. BoNTA was safe and well-tolerated in the study.

Myofascial Trigger Points and Their Relationship to Headache Clinical Parameters in Chronic Tension-Type Headache

2006 ◽  
Vol 46 (8) ◽  
pp. 1264-1272 ◽  
Author(s):  
Cesar Fernandez-de-las-Penas ◽  
Cristina Alonso-Blanco ◽  
Maria Luz Cuadrado ◽  
Robert D. Gerwin ◽  
Juan A. Pareja
Keyword(s):  
Trigger Points ◽  
Tension Type Headache ◽  
Clinical Parameters ◽  
Myofascial Trigger Points ◽  
Chronic Tension Type Headache ◽  
Type Headache

The influence of ictal cutaneous allodynia on the response to occipital transcutaneous electrical stimulation in chronic migraine and chronic tension-type headache: A randomized, sham-controlled study

Cephalalgia ◽  
2014 ◽  
Vol 35 (5) ◽  
pp. 389-398 ◽  
Author(s):  
F Bono ◽  
D Salvino ◽  
MR Mazza ◽  
M Curcio ◽  
M Trimboli ◽  
...  
Keyword(s):  
Electrical Stimulation ◽  
Chronic Migraine ◽  
Tension Type Headache ◽  
Response To Treatment ◽  
Controlled Study ◽  
Transcutaneous Electrical Stimulation ◽  
Chronic Tension Type Headache ◽  
The Real ◽  
Cutaneous Allodynia ◽  
Type Headache

Objective The objective of this article is to determine whether cutaneous allodynia (CA) influences the response to treatment with occipital transcutaneous electrical stimulation (OTES) in chronic migraine (CM) and chronic tension-type headache (CTTH). Methods One hundred and sixty consecutive patients with CM or CTTH were randomized to be treated with real or sham OTES stimulation three times a day for two consecutive weeks. All patients completed the validated 12-item allodynia symptom checklist for assessing the presence and the severity of CA during headache attack. Primary end-point was change (≥50%) in number of monthly headache-free days. Results There was a significant difference in the percentage of responders in the real OTES compared with sham OTES group ( p <0.001). Importantly, there was not a significant change of monthly headache-free days in the allodynic patients with CM and CTTH treated both with real and sham OTES, while the number of headache-free days per month was significantly reduced in the real (86%) but not in the sham group (7%) of non-allodynic patients with CTTH and CM. Conclusions Severe CA is associated with decreased response to treatment with OTES in patients with CM and CTTH.

Sign in / Sign up

Export Citation Format

Share Document